Harm Reduction for People Who Use Drugs (PWUD)

Download PDF

Harm reduction is meant to reduce the negative effects of harmful drug use by providing social, health, and/or job services even if the person receiving these services continues substance use.
  1. Hawk M, Coulter RWS, Egan JE, Fisk S, Reuel Friedman M, Tula M, et al. Harm reduction principles for healthcare settings. Harm Reduct J. 2017 Dec;14(1). Springer Science and Business Media LLC; 2017 Dec. DOI: 10.1186/s12954-017-0196-4.
  2. Ivers JH, Killeen N, Keenan E. Drug use, harm-reduction practices and attitudes toward the utilisation of drug safety testing services in an Irish cohort of festival-goers. Ir J Med Sci. 2022 Aug;191(4):1701-1710. Springer Science and Business Media LLC; 2022 Aug. DOI: 10.1007/s11845-021-02765-2.
  3. Wodak A, Maher L. The effectiveness of harm reduction in preventing HIV among injecting drug users. NSW Public Health Bull. 2010;21(4):69. CSIRO Publishing; 2010. DOI: 10.1071/nb10007.
  4. Strathdee SA, Ricketts EP, Huettner S, Cornelius L, Bishai D, Havens JR, et al. Facilitating entry into drug treatment among injection drug users referred from a needle exchange program: Results from a community-based behavioral intervention trial. Drug Alcohol Dependence. 2006 Jul;83(3):225-232. Elsevier BV; 2006 Jul. DOI: 10.1016/j.drugalcdep.2005.11.015.
  5. Larimer ME. Health Care and Public Service Use and Costs Before and After Provision of Housing for Chronically Homeless Persons With Severe Alcohol Problems. JAMA. 2009 Apr 1;301(13):1349. American Medical Association (AMA); 2009 Apr 1. DOI: 10.1001/jama.2009.414.
  6. Hawk M, Davis D. The effects of a harm reduction housing program on the viral loads of homeless individuals living with HIV/AIDS. AIDS Care. 2012 May;24(5):577-582. Informa UK Limited; 2012 May. DOI: 10.1080/09540121.2011.630352.
  7. Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, et al. Drug checking services for people who use drugs: a systematic review. Addiction. 2022 Mar;117(3):532-544. Wiley; 2022 Mar. DOI: 10.1111/add.15734.
  8. Wallace B, van Roode T, Pagan F, Hore D, Pauly B. The potential impacts of community drug checking within the overdose crisis: qualitative study exploring the perspective of prospective service users. BMC Public Health. 2021 Dec;21(1). Springer Science and Business Media LLC; 2021 Dec. DOI: 10.1186/s12889-021-11243-4.
  9. McClellan C, Lambdin BH, Ali MM, Mutter R, Davis CS, Wheeler E, et al. Opioid-overdose laws association with opioid use and overdose mortality. Addict Behav. 2018 Nov;86:90-95. Elsevier BV; 2018 Nov. DOI: 10.1016/j.addbeh.2018.03.014.
  10. West JC. Case law update: Corporate negligence, peer review information, medical malpractice, good samaritan statute, emergency medicine. J Heal Risk Manag. 2009 Jan;29(1):44-51. Wiley; 2009 Jan. DOI: 10.1002/jhrm.20005.
  11. Razaghizad A, Windle SB, Filion KB, Gore G, Kudrina I, Paraskevopoulos E, et al. The Effect of Overdose Education and Naloxone Distribution: An Umbrella Review of Systematic Reviews. Am J Public Health. 2021 Aug;111(8):e1-e12. American Public Health Association; 2021 Aug. DOI: 10.2105/ajph.2021.306306.
  12. Ma J, Bao YP, Wang RJ, Su MF, Liu MX, Li JQ, et al. Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Mol Psychiatry. 2019 Dec;24(12):1868-1883. Springer Science and Business Media LLC; 2019 Dec. DOI: 10.1038/s41380-018-0094-5.
  13. Jakubowski A, Fox A. Defining Low-threshold Buprenorphine Treatment. J Addict Medicine. 2020 Mar;14(2):95-98. Ovid Technologies (Wolters Kluwer Health); 2020 Mar. DOI: 10.1097/adm.0000000000000555.
  14. Terplan M, Hand DJ, Hutchinson M, Salisbury-Afshar E, Heil SH. Contraceptive use and method choice among women with opioid and other substance use disorders: A systematic review. Prev Medicine. 2015 Nov;80:23-31. Elsevier BV; 2015 Nov. DOI: 10.1016/j.ypmed.2015.04.008.
  15. Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, et al. Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018 Jan 12;67(1):1-31. Centers for Disease Control MMWR Office; 2018 Jan 12. DOI: 10.15585/mmwr.rr6701a1.
  16. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021 Jul 23;70(4):1-187. Centers for Disease Control MMWR Office; 2021 Jul 23. DOI: 10.15585/mmwr.rr7004a1.
  17. Update: Influenza Activity--United States, January 22-28, 2006. PsycEXTRA Dataset. 2006. American Psychological Association (APA); 2006. DOI: 10.1037/e481872006-004.
  18. Samuels EA, Bailer DA, Yolken A. Overdose Prevention Centers: An Essential Strategy to Address the Overdose Crisis. JAMA Netw Open. 2022 Jul 15;5(7):e2222153. American Medical Association (AMA); 2022 Jul 15. DOI: 10.1001/jamanetworkopen.2022.22153.
  19. Bolívar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency Management for Patients Receiving Medication for Opioid Use Disorder. JAMA Psychiatry. 2021 Oct 1;78(10):1092. American Medical Association (AMA); 2021 Oct 1. DOI: 10.1001/jamapsychiatry.2021.1969.
  20. Ivsins A, Boyd J, Beletsky L, McNeil R. Tackling the overdose crisis: The role of safe supply. Int J Drug Policy. 2020 Jun;80:102769. Elsevier BV; 2020 Jun. DOI: 10.1016/j.drugpo.2020.102769.
  21. Buffington DE, Lozicki A, Alfieri T, Bond TC. <p>Understanding factors that contribute to the disposal of unused opioid medication</p>. JPR. 2019 Feb;Volume 12:725-732. Informa UK Limited; 2019 Feb. DOI: 10.2147/jpr.s171742.
  22. Stubbings J, Crawford SY, Menighan TE. A safe in-home disposal system with every opioid prescription? Food and Drug Administration is considering a potential new Risk Evaluation and Mitigation Strategy that could impact pharmacists.. J Am Pharm Assoc (2003). 2022 Mar;62(2):413-418. 2022 Mar. DOI: 10.1016/j.japh.2021.11.009; PubMed PMID: 34872856.
  23. Hurley EA, Goggin K, Piña-Brugman K, Noel-MacDonnell JR, Allen A, Finocchario-Kessler S, et al. Contraception use among individuals with substance use disorder increases tenfold with patient-centered, mobile services: a quasi-experimental study. Harm Reduct J. 2023 Mar 6;20(1). Springer Science and Business Media LLC; 2023 Mar 6. DOI: 10.1186/s12954-023-00760-7.
  24. Nelson NP, Weng MK, Hofmeister MG, Moore KL, Doshani M, Kamili S, et al. Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020. MMWR Recomm Rep. 2020 Jul 3;69(5):1-38. Centers for Disease Control MMWR Office; 2020 Jul 3. DOI: 10.15585/mmwr.rr6905a1.